JMPWA
GNCA

JP Morgan Private Wealth Advisors’s Genocea Biosciences, Inc. GNCA Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-12,285
Closed -$24K – 2078
2021
Q3 		$24K Hold
12,285
– – ﹤0.01% 1927
2021
Q2 		$29K Buy
+12,285
New +$29.6K ﹤0.01% 1888

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

JP Morgan Private Wealth Advisors's GNCA Position: Q4 2021 in Review

JP Morgan Private Wealth Advisors sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2021, closing a stake of 12,285 shares — an estimated $24K sold.

JP Morgan Private Wealth Advisors first reported a position in GNCA in Q2 2021 and held it in 2 quarters. The position peaked at $29K in Q2 2021. 41 funds tracked by Wall St. Rank hold GNCA as of Q4 2021.

  • JP Morgan Private Wealth Advisors reported no remaining Genocea Biosciences, Inc. position as of Q4 2021 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 12,285 Genocea Biosciences, Inc. shares in Q4 2021, an estimated $24K.
  • JP Morgan Private Wealth Advisors first reported a position in Genocea Biosciences, Inc. in Q2 2021 and held it in 2 quarters.
  • JP Morgan Private Wealth Advisors's Genocea Biosciences, Inc. position peaked at $29K in Q2 2021.
  • 41 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2021.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.